CCIA
ELGX

Campbell & Co Investment Adviser’s Endologix Inc ELGX Stock Holding History

Campbell & Co Investment Adviser’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,237
Closed -$103K – 171
2016
Q1 		$103K Buy
+1,237
New +$102K 0.38% 110
2014
Q4 		– Sell
-4,310
Closed -$457K – 303
2014
Q3 		$457K Buy
+4,310
New +$601K 0.23% 132
2013
Q3 		– Sell
-3,517
Closed -$467K – 408
2013
Q2 		$467K Buy
+3,517
New +$497K 0.09% 215

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Campbell & Co Investment Adviser's ELGX Position: Q2 2016 in Review

Campbell & Co Investment Adviser sold out of Endologix Inc (ELGX) in Q2 2016, closing a stake of 1,237 shares — an estimated $103K sold.

Campbell & Co Investment Adviser first reported a position in ELGX in Q2 2013 and held it in 3 quarters. The position peaked at $467K in Q2 2013. 163 funds tracked by Wall St. Rank hold ELGX as of Q2 2016.

  • Campbell & Co Investment Adviser reported no remaining Endologix Inc position as of Q2 2016 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 1,237 Endologix Inc shares in Q2 2016, an estimated $103K.
  • Campbell & Co Investment Adviser first reported a position in Endologix Inc in Q2 2013 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Endologix Inc position peaked at $467K in Q2 2013.
  • 163 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2016.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2016, filed 15 Aug 2016.